Home / Share Price Target / Zimlab
ZIM Laboratories Share Price Target From 2024, 2025 to 2039
ZIM Laboratories Limited | |||
 | Symbol: ZIMLAB | ||
| Price: ₹115.05 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers - Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: ZIM Laboratories Share Price Target For 2024
- 1.1.1: ZIM Laboratories Share Price Target Table For 2024
- 1.1.2: Summary: ZIM Laboratories Share Price Prediction For 2024
- 1.2: ZIM Laboratories Share Price Target For 2025
- 1.2.1: ZIM Laboratories Share Price Target Table For 2025
- 1.2.2: Summary: ZIM Laboratories Share Price Prediction For 2025
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: ZIM Laboratories Long Term Share Price Prediction Chart From 2024, 2025 to 2039
- 2.2: ZIM Laboratories Share Price Target Table From 2024, 2025 to 2039
- 3: ZIM Laboratories Brief Company Overview
- 3.1: ZIM Laboratories Limited: Enhancing Healthcare Worldwide
- 3.2: ZIM Laboratories Financial Performance
- 4: ZIM Laboratories Past Performance
Updated: Wed 08 May 2024
To predict the ZIM Laboratories's future market prices, we harnessed 2 dynamic approaches:
Advertisement
Approach 1: Technical Analysis Paired With Price Action
ZIM Laboratories Share Price Target For 2024
The line chart displays the yearly closing prices of ZIM Laboratories over the past 7 years with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for ZIM Laboratories shares in 2024, see the table below.
Advertisement
ZIM Laboratories Share Price Target Table For 2024
| ZIM Laboratories's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 124.00 (+7.77%) | Price Action: Oct 2023 High |
| 2024 Target 2 | 122.67 (+6.62%) | Price Action: Dec 2022 High |
| 2024 Target 1 | 121.20 (+5.34%) | Price Action: Dec 2023 High |
| Current Price | 115.05 | ZIM Laboratories's 1 share price as of Wed 08 May 2024 |
| Stop Loss 1 | 112.31 (-2.39%) | Technical Indicator: MA250 |
| Stop Loss 2 | 111.19 (-3.36%) | Price Action: Chart |
| Stop Loss 3 | 109.13 (-5.15%) | Fibonacci Retracement Level 50% |
Summary: ZIM Laboratories Share Price Prediction For 2024
In summary, ZIM Laboratories has declined by ₹-0.30, recording a notable -0.26% decrease from 1st January 2024 to 08 May 2024. Despite the setback, our analysis of ZIM Laboratories for 2024 predicts an additional rise of 5.34% to 7.77% by the end of 2024 with three potential targets T1: 121.20, T2: 122.67, T3: 124.00. Stop Loss at SL1: 112.31, SL2: 111.19, SL3: 109.13.
ZIM Laboratories has a 52-week high of ₹152.69, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹73.95, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for ZIM Laboratories.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
ZIM Laboratories Share Price Target For 2025
The line chart displays the yearly closing prices of ZIM Laboratories over the past 7 years with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for ZIM Laboratories shares in 2025, see the table below.
Advertisement
ZIM Laboratories Share Price Target Table For 2025
| ZIM Laboratories's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 175.96 (+52.94%) | Price Action: Chart |
| 2025 Target 2 | 172.68 (+50.09%) | Fibonacci Extension Level 123.6% |
| 2025 Target 1 | 169.99 (+47.75%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 115.05 | ZIM Laboratories's 1 share price as of Wed 08 May 2024 |
| Stop Loss 1 | 102.15 (-11.22%) | Price Action: Jan 2023 High |
| Stop Loss 2 | 101.00 (-12.22%) | Price Action: 02 Apr 2024 High |
| Stop Loss 3 | 99.85 (-13.22%) | Price Action: 04 Apr 2024 High |
Summary: ZIM Laboratories Share Price Prediction For 2025
In summary, ZIM Laboratories has declined by ₹-0.30, recording a notable -0.26% decrease from 1st January 2024 to 08 May 2024. Despite the setback, our analysis of ZIM Laboratories for 2025 predicts an additional rise of 47.75% to 52.94% by the end of 2025 with three potential targets T1: 169.99, T2: 172.68, T3: 175.96. Stop Loss at SL1: 102.15, SL2: 101.00, SL3: 99.85.
ZIM Laboratories has a All-Time high of ₹152.70, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹73.95, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for ZIM Laboratories, we have created a specific page for that check here: ZIM Laboratories Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
ZIM Laboratories Long Term Share Price Prediction Chart From 2024, 2025 to 2039
This chart presents a detailed projection of ZIM Laboratories share price predictions from 2024, 2025 to 2039. This share price Prediction represents a CAGR of 3.17% over the next 15 years.
For complete year by year ZIM Laboratories long term share price target from 2024, 2025 to 2039 check the below table.
Advertisement
ZIM Laboratories Share Price Target Table From 2024, 2025 to 2039
| Year | ZIM Laboratories Target | YoY Change % |
|---|---|---|
| 2024 | ₹115.05 | [Current Price] |
| 2024 | ₹116.41 | 1.18% |
| 2025 | ₹131.88 | 13.28% |
| 2026 | ₹129.89 | -1.51% |
| 2027 | ₹133.58 | 2.84% |
| 2028 | ₹136.76 | 2.38% |
| 2029 | ₹139.29 | 1.84% |
| 2030 | ₹156.81 | 12.57% |
| 2031 | ₹153.56 | -2.08% |
| 2032 | ₹157.06 | 2.27% |
| 2033 | ₹159.98 | 1.85% |
| 2034 | ₹162.16 | 1.36% |
| 2035 | ₹181.75 | 12.08% |
| 2036 | ₹177.22 | -2.5% |
| 2037 | ₹180.55 | 1.87% |
| 2038 | ₹183.20 | 1.46% |
| 2039 | ₹180.13 | -1.68% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
ZIM Laboratories Brief Company Overview
ZIM Laboratories Limited: Enhancing Healthcare Worldwide
Established in 1984 and headquartered in Nagpur, India, ZIM Laboratories Limited is a reputable manufacturer of generic pharmaceutical and nutraceutical products.
The company's diverse product range encompasses pre-formulation intermediates and finished formulations in various oral solid dosage forms. ZIM's offerings extend across therapeutic areas such as urology, gastroenterology, CNS, antibiotics, anti-infectives, NSAIDs/pain analgesics, and vitamins and supplements.
ZIM's commitment to innovation is evident in its modified release patterns, providing enhanced efficacy and patient convenience. With a strong presence in India and international markets, the company continues to contribute to global healthcare.
ZIM Laboratories Financial Performance
| Metric | Value | Description |
|---|---|---|
| Revenue Growth (Quarterly) | -4.6% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | -27.51% | Change in earnings compared to the same quarter last year. |
| Operating Margin | 7.89% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 4.61% | Net income as a percentage of revenue, after all expenses. |
| Debt-to-Equity (D/E) Ratio | 27.61 | Company's total debt divided by total shareholder equity. |
| Beta | 0.58 | Beta is less than 1 indicating that the ZIM Laboratories's price is less volatile than the market. |
Financial Overview of ZIM LaboratoriesRevenue and Profitability:
- Generated revenue of ₹355.05 Crore in the last 12 months (TTM).
- Posted a net profit of ₹16.39 Crore during the same period.
- Profit margin: 4.61%.Debt and Cash Position:
- Declared a debt of ₹62.41 Crore in their Q3-2023-24 Quarterly Report.
- Maintained a cash balance of ₹17.16 Crore as of Q3-2023-24.Recent Performance:
- Revenue declined by 4.6% compared to the previous quarter.
- Earnings witnessed a 27.51% decline compared to the same quarter last year.Summary:ZIM Laboratories, a smallcap stock with a market capitalization of ₹589.87 Crore, has recorded a modest revenue and profit performance over the last 12 months. However, recent quarterly results indicate a decline in revenue and earnings. The company manages a moderate debt level and maintains a reasonable cash balance. Investors may want to monitor the company's future performance to assess its growth prospects.
ZIM Laboratories Past Performance
- In 2018, ZIM Laboratories opening price was ₹80
- As of Wed 08 May 2024 the price stands at ₹115.05.
- This represents a Compound Annual Growth Rate (CAGR) of 5.33%.
- In 6 years, an investment of 10,000 would have become ₹14,381.25.
As we wrap up, we hope you like our study on ZIM Laboratories share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- ZIM Laboratories Share Price History
- ZIM Laboratories Price Target Tomorrow
- ZIM Laboratories Bonus History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
